Publications by authors named "Marium Shamaa"

Claim this Profile
D
Design and synthesis of pyrazolopyrimidinone derivatives as dual VEGFR/Aurora kinase inhibitors against hepatocellular and breast carcinomas.
Kurls E Anwer, Botros Y Beshay, Marium M Shamaa, Nour E A Abd El-Sattar, Amira Senbel

Biomed Pharmacother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of thromboinflammation by rivaroxaban ameliorates metabolic and structural manifestations of metabolic dysfunction-associated steatohepatitis in rats: Comparison to other antithrombotic drugs.
Basant Rageh, Marium Shamaa, Mahmoud Agami, Ahmed F El-Yazbi, Ahmed Wahid

J Pharmacol Exp Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Targeting of Hepatocellular Carcinoma via Novel Regorafenib Combinations with Diosmin, Sulfasalazine, or Rosuvastatin.
Marium M Shamaa

Biochem Genet· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 1,2,4-triazole and 1,3,4-oxadiazole derivatives as inhibitors for STAT3 enzymes of breast cancer.
Sherif M Fawzy, Yasser M Loksha, Mohamed El-Sadek, Samy M Ibrahim, Botros Y Beshay, Marium M Shamaa

Arch Pharm (Weinheim)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy-Apoptosis Molecular Crosstalk.
Basant M Salama, Maged W Helmy, Hosny Fouad, Marium M Shamaa, Maha E Houssen

Curr Issues Mol Biol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental design of D-α-tocopherol polyethylene glycol 1000 succinate stabilized bile salt based Nano-vesicles for improved cytotoxicity and bioavailability of colchicine binding site inhibitor Candidates: In Vitro, in silico, and pharmacokinetic studies.
Ayman Abo Elmaaty, Ahmed A Al-Karmalawy, Mohamed S Nafie, Marium M Shamaa, Islam Zaki

Int J Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan Surface-Modified PLGA Nanoparticles Loaded with Cranberry Powder Extract as a Potential Oral Delivery Platform for Targeting Colon Cancer Cells.
Mona M Mostafa, Maha M Amin, Mohamed Y Zakaria, Mohammed Abdalla Hussein, Marium M Shamaa

Pharmaceutics· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways.
Heba A S El-Nashar, Haidy Abbas, Mariam Zewail, Mohamed H Noureldin, Mai M Ali, Marium M Shamaa

Pharmaceuticals (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Green Synthesis and Tailoring of Vitamin E TPGS Augmented Niosomal Nano-Carrier of Pyrazolopyrimidines as Potential Anti-Liver and Breast Cancer Agents with Accentuated Oral Bioavailability.
Kurls E Anwer, Nour E A Abd El-Sattar, Marium M Shamaa, Mohamed Y Zakaria, Botros Y Beshay

Pharmaceuticals (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Ahmed M Farghaly, Omaima M AboulWafa, Hoda H Baghdadi, Heba A Abd El Razik, Samir M Y Sedra, Marium M Shamaa

Bioorg Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins.
Marium M Shamaa

FEBS Open Bio· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis